Compare CCEL & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCEL | PIII |
|---|---|---|
| Founded | 1989 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 33.8M |
| IPO Year | 2022 | 2021 |
| Metric | CCEL | PIII |
|---|---|---|
| Price | $4.56 | $10.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 4 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 18.2K | ★ 33.0K |
| Earning Date | 04-14-2026 | 05-14-2026 |
| Dividend Yield | ★ 4.26% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | $25,384,279.00 | ★ $1,459,080,000.00 |
| Revenue This Year | N/A | $7.67 |
| Revenue Next Year | N/A | $2.36 |
| P/E Ratio | $59.71 | ★ N/A |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $2.72 | $1.52 |
| 52 Week High | $5.01 | $16.89 |
| Indicator | CCEL | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 70.12 | 46.30 |
| Support Level | $3.10 | $9.71 |
| Resistance Level | $4.41 | $11.55 |
| Average True Range (ATR) | 0.36 | 0.98 |
| MACD | 0.07 | -0.10 |
| Stochastic Oscillator | 68.93 | 15.05 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.